Industry News
Pharmaceutical Industry News
Ozempic Could Prevent Diabetes. Should We Use It For That?
New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a use for the drugs.
What Democrats Should Learn From Their Loss
Readers point to campaign missteps and offer advice for winning back voters. Also: Robert F. Kennedy Jr.’s role in health policy; closing local pharmacies.
Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.
Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of Innovation
Dr. Richard Pazdur for 25 years has overseen innovations in the treatment of deadly diseases at the agency.
What to Know About Plan B: Cost, Effectiveness and Legality
We asked experts how it works, when you should take it, how much it costs and more.
F.D.A. Wants to Pull Ineffective Decongestant From Stores
It was added to cold and flu remedies in the 1990s when another ingredient went behind the counter over illicit meth lab concerns.
Robert F. Kennedy Jr. se prepara para ejercer el poder en salud pública
El presidente electo, Donald Trump, lo ha animado a “descocarse en materia de salud”, pero no ha aclarado qué papel jugará Kennedy.
Robert F. Kennedy Jr., Foe of Drug Makers and Regulators, Is Poised to Wield New Power
President-elect Donald Trump has encouraged him to “go wild on health” but has not made clear what role Mr. Kennedy will play.
El medicamento innovador para vencer la adicción: ¿Ozempic?
Los primeros datos sugieren que los fármacos GLP-1, conocidos por su capacidad para ayudar a perder peso, podrían tener un poderoso efecto en el tratamiento de la adicción.
Chronic Diseases Can Come With Chronic Financial Pressure
For millions of Americans, paying for the treatment needed to manage their diseases can become its own lifelong problem.
It’s Time to Shop for Medicare, and 2025 Brings Big Changes
A bumper crop of revisions, including a stronger drug benefit, means the plan you enrolled in for 2024 may not be the best fit next year.
From AI to Musk’s Brain Chip, the F.D.A.’s Device Unit Faces Rapid Change
The new director overseeing medical devices will confront criticisms about hasty approvals as she ushers in revolutionary technology.
How a Second Trump Term Could Recast Public Health
Breaking up the C.D.C., moving funds from the N.I.H. — conservatives have floated changes should Mr. Trump regain office.
R.F.K. Jr. Said Trump Promised Him Control of Public Health Agencies. The Campaign Called That Premature.
The onetime independent presidential candidate, who dropped out and is backing Donald J. Trump, has in recent years promoted unproven theories about the dangers of pharmaceutical treatments.
Can John Green Make You Care About Tuberculosis?
With a forthcoming nonfiction book and an online army of Nerdfighters, the young-adult author aims to eliminate an entirely curable global scourge.
How The Opioid Crisis Turned Pharmacists Into Cops
How the opioid crisis changed pharmacists’ relationships with their patients.
Jill Stein’s Third-Party Candidacy
Readers discuss Democrats’ concerns that her bid will throw the election to Donald Trump. Also: Harris ads; drug-free treatments; regretting email.
U.S. Study on Puberty Blockers Goes Unpublished Because of Politics, Doctor Says
The leader of the long-running study said that the drugs did not improve mental health in children with gender distress and that the finding might be weaponized by opponents of the care.
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.
Biden Mocks Trump’s ‘Concept of a Plan’ to Replace Obamacare
During a visit to New Hampshire to discuss the cost of prescription drugs, President Biden warned that a second Trump presidency could lead millions of people to lose health care.